AzTrials
AzTrials

Bowel PreparationDinNER1006NCT06651398

A Study to Investigate the Effect of a Meal At 6pm the Day Before the Colonoscopy on the Bowel Cleansing with Plenvu

A study testing Lenient diet in people with Bowel Preparation and Bowel Preparation for Colonoscopy, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Bowel cleansing prior to colonoscopy is crucial to be able to perform a high-quality examination. Therefore maximum efforts are made to achieve optimal bowel cleansing including diet restriction and refraining from day-before dinner. However, the effect of this interdiction is currently not clear. Read more about this study

Who is it for?
Ages 40 to 85 yearsHealthy volunteers can take part
What is being tested?
Lenient diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
525 participants
Where
1 siteBelgium
Study dates
14 Feb 2023to Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patient referred for diagnostic colonoscopy
  • Age between 40 and 85 years old
  • Ability of normal oral ingestion
  • Able to give informed consent by the patient or the legal representative

Who cannot join

  • Participant has a history of (partial) colectomy, excluding appendectomy
  • Inability of oral ingestion
  • Chronic severe constipation, defined as the need for daily laxative use of any kind or the need to use laxatives to obtain defaecation.
  • Uncontrolled coagulopathy
  • Pregnancy
  • Premenopausal women not adhering to any contraceptive method
Show all 19Show fewer
  • Inflammatory bowel disease
  • Lynch syndrome
  • Familial adenomatosis polyposis syndrome
  • Serrated polyposis syndrome
  • hypersensitivity to the active substances of PLENVU as listed in the SmPC section 6.1
  • gastrointestinal obstruction or perforation
  • ileus
  • gastric emptying disorders (e.g. gastroparesis, gastric retention, etc.)
  • phenylketonuria (due to the presence of aspartame in PLENVU)
  • glucose-6-phosphate dehydrogenase deficiency (due to the presence of ascorbate in PLENVU)
  • toxic megacolon
  • Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol
  • Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • UZ Leuven

    Leuven, Vlaams-Brabant, 3000

Other trials in Belgium

About this study

Official title: To Dine or Not to Dine: Effect of Day-before Light Dinner on Bowel Cleansing Prior to Colonoscopy

Bowel cleansing prior to colonoscopy is crucial to be able to perform a high-quality examination. Therefore maximum efforts are made to achieve optimal bowel cleansing including diet restriction and refraining from day-before dinner. However, the effect of this interdiction is currently not clear. On the other hand, patient compliance and experience with the entire procedure is important, especially for follow-up colonoscopies. Strict diets may interfere with this as an additional burden on the patient. In this study we want to assess whether a more lenient diet influences the quality of bowel preparation and whether it improves patient's experience.

Being tested
Lenient diet
Keywords
bowel preparation, colonoscopy preparation, bowel cleansing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lenient dietBehavioural

    The interventional goup receives the lenient diet instructions and will eat a light meal until 18h on the day before the colonoscopy. The first dose of Plenvu will be started at 20h. All the other bowel preparation instructions will be the same as in the control group.

Study groups in NCT06651398
Study groupRoleWhat they receive
Lenient dietExperimentalThis group can have a less stringent diet compared to the current standard of care and eat a light meal until 18h before drinking the first dose of the bowel preparation on the day before the colonoscopy
Receives: Behavioral: Lenient diet
Control groupNo interventionThis group follows the strict diet similar to what is currently used in standard of care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with an adequate bowel preparation (BBPS ≥6, and no segmental subscore ≤1)

    Measured: Max 12 weeks

Secondary outcomes (4)
  1. Number of patients with an optimal bowel preparation (BBPS 8-9)

    Measured: Max 12 weeks

  2. Detection rates

    Adenoma Detection Rate (ADR), Polyp Detection Rate (PDR), Serrated Polyp Detection Rate (SPDR), Advanced Adenoma Detection Rate (aADR)

    Measured: Max 12 weeks

  3. Number of patients with high-quality right sided colon preparation (subscore = 3)

    Measured: Max 12 weeks

  4. Overall patient's tolerance, adherence and satisfaction based on the patient's diary

    Measured: Max 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2024
  2. Study start14 Feb 2023
  3. Primary completionNov 2024 (estimated)
  4. Study completionNov 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
525 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06651398
Sponsor's protocol ID
S66191
Acronym
DinNER1006
Status last verified
Oct 2024
First submitted
18 Oct 2024
Last updated
21 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Lenient diet in people with Bowel Preparation and Bowel Preparation for Colonoscopy, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with an adequate bowel preparation (BBPS ≥6, and no segmental subscore ≤1) (time frame: Max 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in